Immediate Impact
5 from Science/Nature 69 standout
Citing Papers
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
2025 Standout
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
2025 Standout
Works of Yuko Waseda being referenced
Efficacy and safety of nanoparticle albumin‐bound paclitaxel monotherapy after immune checkpoint inhibitor administration for advanced non‐small cell lung cancer: A multicenter Phase 2 clinical trial
2023
Safety and tolerability of combination therapy with pirfenidone and nintedanib for idiopathic pulmonary fibrosis: A multicenter retrospective observational study in Japan
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Yuko Waseda | 527 | 323 | 130 | 232 | 53 | 900 | |
| Deborah Belchis | 334 | 217 | 48 | 200 | 43 | 1.1k | |
| Kenichiro Hara | 308 | 200 | 155 | 130 | 35 | 800 | |
| Lea F. Surrey | 327 | 396 | 56 | 147 | 76 | 1.2k | |
| Joseph Kovi | 458 | 155 | 47 | 221 | 52 | 1.1k | |
| J. Kenneth Schoolmeester | 322 | 155 | 118 | 197 | 54 | 863 | |
| M. Carmen Gonzaléz‐Vela | 266 | 145 | 116 | 316 | 36 | 876 | |
| Tadashi Kamei | 501 | 117 | 208 | 71 | 40 | 852 | |
| Gunnar Mårtensson | 499 | 124 | 60 | 117 | 49 | 1.0k | |
| Qingjun Wu | 195 | 257 | 81 | 472 | 82 | 961 | |
| A. Le Duc | 383 | 117 | 57 | 81 | 64 | 1.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...